These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8259791)

  • 1. Hormone replacement therapy: the need for reconsideration.
    Rosenberg L
    Am J Public Health; 1993 Dec; 83(12):1670-3. PubMed ID: 8259791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menopause and hormone replacement therapy.
    Speroff L
    Clin Geriatr Med; 1993 Feb; 9(1):33-55. PubMed ID: 8443739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormone replacement therapy. Clinical synthesis panel on HRT.
    J Epidemiol Biostat; 1999; 4(3):123-8. PubMed ID: 10695954
    [No Abstract]   [Full Text] [Related]  

  • 6. Benefits and risks of estrogen replacement therapy.
    Lobo RA
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 2):982-9. PubMed ID: 7573295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
    Parish SJ; Gillespie JA
    Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease.
    Whittington R; Faulds D
    Pharmacoeconomics; 1994 Jun; 5(6):513-54. PubMed ID: 10147266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The benefits and risks of hormone replacement therapy: an epidemiologic overview.
    Harlap S
    Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):1986-92. PubMed ID: 1605289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriate use of hormones should alleviate concerns of cardiovascular and breast cancer risk.
    Lobo RA
    Maturitas; 2005 May; 51(1):98-109. PubMed ID: 15883114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rationale for a wider range of progestogens.
    Skouby SO
    Climacteric; 2000 Dec; 3 Suppl 2():14-20. PubMed ID: 11379382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacology of estrogens: cardiovascular actions and cardioprotective benefits of replacement therapy in postmenopausal women.
    Schwartz J; Freeman R; Frishman W
    J Clin Pharmacol; 1995 Jan; 35(1):1-16. PubMed ID: 7751408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health.
    de Villiers TJ; Pines A; Panay N; Gambacciani M; Archer DF; Baber RJ; Davis SR; Gompel AA; Henderson VW; Langer R; Lobo RA; Plu-Bureau G; Sturdee DW;
    Climacteric; 2013 Jun; 16(3):316-37. PubMed ID: 23672656
    [No Abstract]   [Full Text] [Related]  

  • 15. Update on hormone replacement therapy.
    Gambrell RD
    Am Fam Physician; 1992 Nov; 46(5 Suppl):87S-96S. PubMed ID: 1442475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risks, benefits and costs of hormone replacement therapy in menopause].
    Gaspard U
    Rev Med Liege; 1998 May; 53(5):298-304. PubMed ID: 9689887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are progestins really necessary as part of a combined HRT regimen?
    Sturdee DW
    Climacteric; 2013 Aug; 16 Suppl 1():79-84. PubMed ID: 23651281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy: revisiting the risk of breast cancer.
    Franceschini G; Lello S; Masetti R
    Eur J Cancer Prev; 2020 Jul; 29(4):303-305. PubMed ID: 31567535
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical pharmacology of estrogens: cardiovascular actions and cardioprotective benefits of replacement therapy in postmenopausal women.
    Schwartz J; Freeman R; Frishman W
    J Clin Pharmacol; 1995 Mar; 35(3):314-29. PubMed ID: 7608324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menopausal hormone therapy and cancer risk: An overestimated risk?
    Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
    Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.